Global Long-term Outcomes and Real-World Evaluation of Dexcom Continuous Glucose Monitoring System (Dexcom GLOW)

NCT07681024 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 5000

Last updated 2026-07-02

No results posted yet for this study

Summary

Global Registry study

Conditions

Interventions

DEVICE

Dexcom CGM (Continuous Glucose Monitor)

Use Dexcom CGM according to approved commercial use. Evaluate HbA1c over time.

Sponsors & Collaborators

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-06-15
Primary Completion
2030-05-01
Completion
2030-05-01
FDA Device
Yes

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07681024 on ClinicalTrials.gov